Drug Profile
Ecraprost - LTT Bio-Pharma
Alternative Names: AS 013; LT 2001Latest Information Update: 01 Dec 2017
Price :
$50
*
At a glance
- Originator LTT Bio-Pharma
- Class Prostaglandins
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Peripheral arterial occlusive disorders
Most Recent Events
- 01 Dec 2017 Phase-II development for Peripheral arterial occlusive disorders is ongoing in Japan (LTT Bio-Pharma pipeline, December 2017)
- 10 May 2010 Phase-II clinical trials in Peripheral arterial occlusive disease in Japan (unspecified route)